CVE-2026-21974 MEDIUM

CVE-2026-21974

Vendor Oracle Corporation
Product Oracle Life Sciences Central Designer
Published January 20, 2026
Last update January 21, 2026
View on NVD All CVEs

CVSS base score

5.3/10
Attack vector Network
Attack complexity Low
Privileges required None
User interaction None
Confidentiality Low
Integrity None

CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

What the vulnerability does

01Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Key dates

02Disclosure timeline

January 20, 2026 CVE published
January 21, 2026 Record updated